International Clinical Trial: Evaluation of the Efficacy and Safety of Oral Probiotics in Improving Diarrhea-Predominant Irritable Bowel Syndrome: A Single-Center, Open-Label, Randomized, Placebo-Controlled Study

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121840) titled 'Evaluation of the Efficacy and Safety of Oral Probiotics in Improving Diarrhea-Predominant Irritable Bowel Syndrome: A Single-Center, Open-Label, Randomized, Placebo-Controlled Study' on April 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing University of Chinese Medicine Third Affiliated Hospital

Condition: Irritable Bowel Syndrome

Intervention: Trial Group:Basic treatment + VHProbi C08 probiotic powdered beverage: 1 sachet each time, 3 times daily (morning, afternoon, evening), dissolved in warm water (temperature not exceeding 50?)

Recruitment Status: Not Recruiting ...